<- Go Home
electroCore, Inc.
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Market Cap
$108.7M
Volume
13.5K
Cash and Equivalents
$4.9M
EBITDA
-$11.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$19.4M
Profit Margin
83.32%
52 Week High
$18.67
52 Week Low
$5.32
Dividend
N/A
Price / Book Value
11.42
Price / Earnings
-9.25
Price / Tangible Book Value
11.42
Enterprise Value
$99.8M
Enterprise Value / EBITDA
-8.78
Operating Income
-$12.6M
Return on Equity
123.83%
Return on Assets
-38.23
Cash and Short Term Investments
$12.9M
Debt
$4.0M
Equity
$9.5M
Revenue
$23.3M
Unlevered FCF
-$5.6M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium